vTv Therapeutics (VTVT) Return on Invested Capital (2017 - 2024)
vTv Therapeutics recorded quarterly Return on Invested Capital of 0.02% in Q4 2024, down 19.97% quarter-over-quarter from 0.01% in Q3 2024.
vTv Therapeutics' Return on Invested Capital history runs 7 years deep, the most recent figure standing at 0.02% for Q4 2024.
- In Q4 2024, Return on Invested Capital changed N/A year-over-year to 0.02%; the TTM figure through Dec 2024 stood at 0.02% (changed N/A YoY), while the FY2024 annual figure was 0.05%, changed N/A from the prior year.
- Return on Invested Capital came in at 0.02% for Q4 2024 at vTv Therapeutics, down from 0.01% in the prior quarter.
- In the past five years, Return on Invested Capital ranged from a high of 0.03% in Q2 2022 to a low of 0.36% in Q1 2024.
- A 4-year average of 0.02% and a median of 0.0% in 2021 frame the typical range for Return on Invested Capital.
- Across the five-year window, Return on Invested Capital changed 0 bps in 2020 and climbed 3 bps in 2022, its largest moves.
- vTv Therapeutics' Return on Invested Capital stood at 0.0% in 2020, then jumped by 231 bps to 0.01% in 2021, then increased by 19 bps to 0.02% in 2022, then plunged by 191 bps to 0.02% in 2024.
- According to Business Quant data, Return on Invested Capital over the past three periods registered 0.02%, 0.01%, and 0.01% for Q4 2024, Q3 2024, and Q2 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -0.01% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 0.00% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -0.01% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 0.00% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 0.01% |
| 10 | vTv Therapeutics | 413.85 Mn | 413.85 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -0.02% |
| Sep 30, 2024 | -0.01% |
| Jun 30, 2024 | -0.01% |
| Mar 31, 2024 | -0.36% |
| Dec 31, 2022 | 0.02% |
| Sep 30, 2022 | 0.02% |
| Jun 30, 2022 | 0.03% |
| Mar 31, 2022 | 0.03% |
| Dec 31, 2021 | 0.01% |
| Sep 30, 2021 | 0.00% |
| Jun 30, 2021 | 0.00% |
| Mar 31, 2021 | 0.00% |
| Mar 31, 2020 | 0.00% |
| Dec 31, 2019 | 0.00% |
| Sep 30, 2019 | 0.00% |
| Jun 30, 2019 | 0.00% |
| Mar 31, 2019 | 0.00% |
| Dec 31, 2018 | 0.00% |
| Sep 30, 2018 | 0.01% |
| Jun 30, 2018 | 0.00% |
| Mar 31, 2018 | 0.00% |
| Dec 31, 2017 | 0.00% |